Related references
Note: Only part of the references are listed.PET Radioligands Roveal the Basis of Demetia in Parkinson's Disease and Dementia with Lewy Bodies
Stephen N. Gomperts et al.
NEURODEGENERATIVE DISEASES (2016)
The utility of -synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
Anja Hviid Simonsen et al.
BIOMARKERS IN MEDICINE (2016)
Amyloid PET Imaging in Lewy Body Disorders
Paul Donaghy et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Prevalence of Amyloid PET Positivity in Dementia Syndromes A Meta-analysis
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis
Willemijn J. Jansen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
David R. Howlett et al.
BRAIN PATHOLOGY (2015)
The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?
Flora H. Duits et al.
ALZHEIMERS & DEMENTIA (2014)
Imaging the Role of Amyloid in PD Dementia and Dementia with Lewy Bodies
Stephen N. Gomperts
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2014)
Conversion Between Mini-Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale-2 Scores in Parkinson's Disease
Inger van Steenoven et al.
MOVEMENT DISORDERS (2014)
CSF Aβ42 predicts early-onset dementia in Parkinson disease
Guido Alves et al.
NEUROLOGY (2014)
Concomitant pathologies among a spectrum of parkinsonian disorders
Brittany N. Dugger et al.
PARKINSONISM & RELATED DISORDERS (2014)
Biomarkers in biological fluids for dementia with Lewy bodies
Sebastian Schade et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
APOE, MAPT, and SNCA Genes and Cognitive Performance in Parkinson Disease
Ignacio F. Mata et al.
JAMA NEUROLOGY (2014)
Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies
Hans Brunnstrom et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2013)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies
J. A. Schneider et al.
BRAIN (2012)
Brain amyloid and cognition in Lewy body diseases
Stephen N. Gomperts et al.
MOVEMENT DISORDERS (2012)
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
N. S. M. Schoonenboom et al.
NEUROLOGY (2012)
Neuropathology underlying clinical variability in patients with synucleinopathies
Glenda M. Halliday et al.
ACTA NEUROPATHOLOGICA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
M. Andersson et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Pathological roles of α-synuclein in neurological disorders (vol 10, pg 1015, 2011)
K. Vekrellis et al.
LANCET NEUROLOGY (2011)
Pathological roles of α-synuclein in neurological disorders
Kostas Vekrellis et al.
LANCET NEUROLOGY (2011)
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
Lani K. Clinton et al.
JOURNAL OF NEUROSCIENCE (2010)
Amyloid Imaging of Lewy Body-Associated Disorders
Erin R. Foster et al.
MOVEMENT DISORDERS (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's Disease
Caroline H. Williams-Gray et al.
JOURNAL OF NEUROLOGY (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2008)
Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
Lucilla Parnetti et al.
BIOLOGICAL PSYCHIATRY (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
C. Ballard et al.
NEUROLOGY (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both
ML Kraybill et al.
NEUROLOGY (2005)
Dementia with Lewy bodies: Molecular pathogenesis and implications for classification
JL Cummings
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2004)
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies
AR Merdes et al.
NEUROLOGY (2003)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
